• Home
  • About Us

Idiopathic Pulmonary Fibrosis

Jeremy Feldman, MD

  • What is Idiopathic Pulmonary Fibrosis?
    • Idiopathic Pulmonary Fibrosis Definition
    • Symptoms of Idiopathic Pulmonary Fibrosis
    • Causes of Idiopathic Pulmonary Fibrosis
    • Who Gets Idiopathic Pulmonary Fibrosis
    • Gastro-Esophageal Reflux (GER) and Idiopathic Pulmonary Fibrosis
    • Interstitial Lung Disease vs. Idiopathic Pulmonary Fibrosis
    • Is Pulmonary Fibrosis Hereditary?
    • Research, Life Expectancy and Prognosis for Idiopathic Pulmonary Fibrosis
  • Diagnosing & Monitoring PF
    • Monitoring Progress of IPF
    • Idiopathic Pulmonary Fibrosis Diagnosis
    • Chest X-rays Used in IPF
    • CPET used in IPF
    • HRCT Scans Used to Evaluate IPF
    • Lung Biopsy To Diagnose IPF
    • Pulmonary Function Tests (PFTS)
    • Six Minute Walk Test To Monitor IPF
    • Stages of Idiopathic Pulmonary Fibrosis
    • Complications of Idiopathic Pulmonary Fibrosis
  • PF Treatment Options
    • Esbriet (pirfenidone) Used to Treat IPF
    • OFEV (nintedanib) Used to Treat IPF
    • Pulmonary Rehab for IPF Patients
    • Lung Transplantation for Pulmonary Fibrosis
    • Oxygen Used to Treat IPF
      • Update on Oxygen Use
    • Clinical Trials in Idiopathic Pulmonary Fibrosis
    • IPF & Leg Swelling
    • Pulmonary Hypertension and Idiopathic Pulmonary Fibrosis
    • IPF Exacerbation
  • PF Advocacy & News
  • FAQ’s
    • Respiratory failure, NSIP, diet
    • Leg swelling, lung biopsy, side effects & pets
    • FAQ’s Enzyme Therapy, Progression of IPF & Oxygen
    • FAQ: Diarrhea, Fibrosis Reversal, IPF Symptoms
    • FAQ: Oxygen Flow, Anesthesia & Genetics
    • FAQ: Contagious Cough? Stem Cells, Familial IPF, Flying
    • FAQ: GERD, Fatigue & Environmental Exposure
    • FAQ: How to Travel to Your Doctor’s Office with Oxygen
    • FAQ: Lung Biopsy with Pulmonary Fibrosis
    • FAQ’s: Alcohol, Clinical Trials, Pulmonary Function Testing
    • FAQs: Emphysema, Exercise & Lung Biopsy

Lung Biopsy To Diagnose IPF

Do I Need a Lung Biopsy to Diagnose Idiopathic Pulmonary Fibrosis?

This is a very important question for patients with interstitial lung disease (a large family of lung tissue disorders). There are two broad categories of interstitial lung disorders: those that respond to medicines that suppress your immune system and those that don’t. Diseases such as nonspecific interstitial pneumonitis (NSIP), hypersensitivity pneumonitis (HP) and sarcoid are all examples of lung diseases that improve with immunosuppression (suppression of your immune system). In contrast, idiopathic pulmonary fibrosis does not improve with such treatment. Therefore it is essential to correctly categorize a patient as having IPF versus one of the other disorders.

In some cases, the chest imaging with high resolution chest scanning (HRCT chest) combined with the right history, exam, and pulmonary function findings shows such a characteristic pattern as to make a lung biopsy unnecessary. In most other cases, a lung biopsy should be performed.

Questions to Consider Prior to Having a Lung Biopsy

lung biopsy to diagnose Idiopathic Pulmonary Fibrosis

 

When I am evaluating a patient with interstitial lung disease, I am really asking several basic questions.

  1. Does this patient have IPF?
  2. If this is not IPF, can I determine which other type of lung disease the patient has?
  3. If this is not IPF, is there a reason not to use immunosuppression?
  4. If I am considering lung biopsy, can the patient tolerate the procedure?

 

Let’s start with the first question.

The following features should be present at a minimum to diagnose IPF without a lung biopsy.

  1. Age greater than 50
  2. Absence of connective tissue diseases such as lupus, rheumatoid arthritis or scleroderma
  3. HRCT chest should show lower lobe, subpleural (just below the surface of the lung) and posterior predominant reticulation (scarring)
  4. Although not absolutely essential, honeycomb change and the absence of ground glass (inflammatory findings on HRCT) are strongly supportive

Features which are supportive of IPF

  1. Lung base crackles on exam
  2. Clubbing of the digits (nail bed changes)
  3. Nonproductive or dry cough
  4. Slowly progressive symptoms
  5. Pulmonary function findings of restriction (small lung volumes)

If there is an upper lobe predominance, extensive ground glass findings or air trapping this should raise concern for another diagnosis and lung biopsy should be considered.

Who Should Not Have a Lung Biopsy Under Any Circumstances?

  1. Patients who are so sick they will die during the procedure
  2. Patients with end-stage fibrotic lung disease
  3. Patients who are on Plavix or other blood thinners/antiplatelet agents (except aspirin) that can’t be safely stopped
  4. Patients who are not interested in treatment regardless of the findings

If I Need a Surgical Lung Biopsy, How Should it be Performed?

Lung biopsy should be performed by a cardiothoracic surgeon expert in VATS (video assisted thoracoscopic surgery). This means that two small holes are created and telescope-like equipment is then inserted into the chest. At least two and preferably three biopsies should be taken from three lobes of the lung on the same side. The tip of the middle lobe should not be sampled. Ideally, areas of advanced scarring are avoided. Areas of moderate disease are best.

Open surgery with a large incision is avoided to minimize pain and shorten recovery times. Most patients spend one night in the hospital. Surgery is done under general anesthesia. Immediately after surgery patients will wake up with a chest tube in their chest. This is generally removed the next morning.

What are the Risks of Surgery?

  1. Bleeding
  2. Infection
  3. Air leaks. This means that the lung is leaking air into the pleural space (area around the lung but inside the chest cavity). When this occurs, the chest tube must remain in place for longer.
  4. All the usual risks of general anesthesia (problems with putting a breathing tube into the airway such as injury to your teeth, allergic reactions to medicines)

Who Should Review Your Lung Biopsy?IPF lung tissue

Interpreting a lung biopsy is very difficult. Most general pathologists do not have the expertise to confidently tease apart IPF from fibrotic NSIP. As the treatments at present are so different for these two lung disorders, it is essential to get the interpretation correct. There are lung-specialized pathologists that are able to do this. I always send my lung biopsies to a national expert in interstitial lung disease to get a second opinion. This prevents misdiagnosis and treatment errors.

Featured Blog Posts

Interstitial Lung Disease and Progressive Pulmonary Fibrosis

Pulmonary Fibrosis Caregiver

5 Things to Know as a Pulmonary Fibrosis Caregiver

sleep

Sleep Tips for Living with IPF

Recent Posts

  • Nerandomilast in Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis: A Promising New Therapeutic Approach
  • Interstitial Lung Disease and Progressive Pulmonary Fibrosis
  • Pamrevlumab Ineffective in Treating IPF

Search by Keyword (Examples: GERD, Coughing, Traveling, etc.)

Search by Category

Popular Articles

IPF patient with doctor

Idiopathic Pulmonary Fibrosis Treatment Options

What is IPF?

  • What is Idiopathic Pulmonary Fibrosis?
    • Symptoms of Idiopathic Pulmonary Fibrosis
    • Causes of Idiopathic Pulmonary Fibrosis
    • Who Gets Idiopathic Pulmonary Fibrosis
    • Gastro-Esophageal Reflux (GER) and IPF
    • Interstitial Lung Disease vs. Idiopathic Pulmonary Fibrosis
    • Is Pulmonary Fibrosis Hereditary?
    • Research, Life Expectancy & Prognosis for Pulmonary Fibrosis

Diagnosing IPF

  • Idiopathic Pulmonary Fibrosis Diagnosis
    • Chest X-rays Used in IPF
    • CPET used in IPF
    • HRCT Scans Used to Evaluate IPF
    • Lung Biopsy To Diagnose IPF
    • Pulmonary Function Tests (PFTS)
    • Six Minute Walk Test To Monitor IPF
    • Stages of Idiopathic Pulmonary Fibrosis
    • Complications of Idiopathic Pulmonary Fibrosis

Treating IPF

  • Pulmonary Fibrosis Treatment Options
    • Esbriet (pirfenidone) Used to Treat IPF
    • OFEV (nintedanib) Used to Treat IPF
    • Pulmonary Rehab for IPF Patients
    • Lung Transplantation for Pulmonary Fibrosis
    • Oxygen Used to Treat IPF
    • Clinical Trials in Idiopathic Pulmonary Fibrosis
    • IPF & Leg Swelling
    • Pulmonary Hypertension and Idiopathic Pulmonary Fibrosis
    • IPF Exacerbation

Disclaimer